Goldman Sachs Group »

Intellia Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $25M 825k 30.49
2023-09-30 $25M 796k 31.62
2023-06-30 $41M 1.0M 40.78
2023-03-31 $32M 860k 37.27
2022-12-31 $22M 627k 34.89
2022-06-30 $44M 848k 51.76
2022-03-31 $39M 531k 72.67
2021-12-31 $121M 1.0M 118.24
2021-09-30 $130M 970k 134.15
2021-03-31 $63M 786k 80.25
2020-12-31 $58M 1.1M 54.40
2020-09-30 $11M 540k 19.88
2020-06-30 $2.6M 126k 21.02
2019-12-31 $1.4M 94k 14.67
2019-09-30 $2.0M 153k 13.35
2019-06-30 $3.6M 221k 16.37
2019-03-31 $2.3M 135k 17.08
2018-12-31 $2.2M 162k 13.66
2018-09-30 $2.8M 98k 28.62
2018-06-30 $2.4M 87k 27.36
2018-03-31 $691k 33k 21.09
2017-12-31 $2.5M 130k 19.22
2017-09-30 $794k 32k 24.84
2017-06-30 $777k 49k 16.00
2017-03-31 $573k 41k 14.08
2016-12-31 $2.1M 163k 13.10
2016-09-30 $2.7M 156k 17.06
2016-06-30 $3.1M 144k 21.35